Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists

European Journal of Cancer Care
V Regnier DenoisF Chauvin

Abstract

Oral chemotherapy is increasingly used in oncology. Poor adherence, that is, non-respect of medical advice about taking the therapy and surveillance of adverse effects, is the main risk associated with this administration route. Poor adherence may be explained by non-adherence by the patient to the treatment, misunderstanding the advice or it could also reflect the poor adaptation of the healthcare team to a new administration route. Here we report the results from a qualitative study that aimed to describe and understand existing practice for capecitabine, an oral chemotherapy, which is used for the treatment of metastatic breast and colon cancer. We interviewed 42 patients who were receiving oral capecitabine in groups and individually as well as 10 prescribers. This study was carried out in two specialist cancer centres. The results showed a wide diversity in the prescribers' practices, who make decisions based on their experience of practice guidelines for intravenous chemotherapies. Although the results for the patients do not suggest deliberate non-adherence, they show poor observance of the dose schedule. The most important result of this study is the patient's inability to identify and to report important signs of harmf...Continue Reading

References

Jan 1, 1990·Cancer·A H LebovitsM R Messe
Mar 8, 1997·BMJ : British Medical Journal·P D Mullen
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J L BlumT Griffin
May 5, 2000·Social Science & Medicine·M A ChesneyL Sherr
Aug 18, 2000·Qualitative Health Research·P S Kidd, M B Parshall
May 2, 2002·Journal of the National Cancer Institute·Ann H PartridgeEric P Winer
Jun 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J CassidyUNKNOWN Capecitabine Colorectal Cancer Study Group
Nov 16, 2002·British Journal of Cancer·V J O'Neill, C J Twelves
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann H PartridgeJerry Avorn
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Ian ChauPierre Fumoleau
Apr 29, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Louise Atkins, Lesley Fallowfield
Aug 3, 2006·European Journal of Cancer Care·J L G NilssonJ Moen
Dec 16, 2006·British Journal of Community Nursing·Paula Escalada, Peter Griffiths
Jan 24, 2007·Cancer·Thomas I BarronM John Kennedy
Jan 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann H PartridgeAviva Asnis-Alibozek
Apr 9, 2008·Clinical Journal of Oncology Nursing·Christine MiaskowskiRowan T Chlebowski

❮ Previous
Next ❯

Citations

May 28, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jasem Al-Barrak, Winson Y Cheung
Jun 6, 2013·International Journal of Clinical Pharmacy·Vanessa HegeleLuciane Pereira Lindenmeyer
Nov 29, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M T E PutsS M H Alibhai
Aug 22, 2013·Nursing·Monica P Davey
Feb 17, 2015·Expert Review of Anticancer Therapy·Susanne Liewer, Ashley N Huddleston
Feb 3, 2016·Seminars in Oncology Nursing·Janet H Van CleaveMartine Puts
Jan 23, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sheetal M KircherYu-Ning Wong
Mar 5, 2016·Expert Review of Anticancer Therapy·Wen-Chuan HuangChao-Sung Chang
Oct 2, 2013·European Journal of Cancer Care·F BassanC Tarquinio
Jun 21, 2012·Pediatric Hematology and Oncology·Julien ManciniPascal Auquier
Apr 18, 2016·Current Hematologic Malignancy Reports·Jeffrey BetcherNandita Khera
Apr 16, 2015·BMJ Open·Kaori YagasakiTsunehiro Takahashi
Oct 2, 2013·Clinical Journal of Oncology Nursing·Kaori Yagasaki, Hiroko Komatsu
May 21, 2016·Clinical Journal of Oncology Nursing·Kristine B LeFebvre, Toni L Felice
Jul 28, 2016·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Catherine GassmannAndrea Brenner
Oct 7, 2016·Frontiers in Pharmacology·Lonneke TimmersJacqueline G Hugtenburg
Jun 22, 2017·Japanese Journal of Clinical Oncology·Chieko HiraoNoriko Yamamoto-Mitani
Aug 5, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Jelena RosentreterIrene Krämer
Feb 1, 2017·Current Geriatrics Reports·Charles W Given, Barbara A Given
Nov 24, 2017·Cancer Medicine·Christel C L M BoonsJacqueline G Hugtenburg
Jul 11, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jennifer A BelskyMelissa J Rose
May 30, 2013·American Society of Clinical Oncology Educational Book·Winson Y Cheung
Sep 26, 2012·The Patient·Rachael Gooberman-Hill
Jan 21, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Marília B VisacriPatricia Moriel
Nov 7, 2020·Obstetrics and Gynecology·Catherine H WatsonBrittany A Davidson
May 1, 2021·International Journal of Environmental Research and Public Health·Amparo TalensElsa López-Pintor
Mar 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M T E PutsS M H Alibhai
Oct 1, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Aurelie FeralAurelie Lenglet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Ann H PartridgeHyman Muss
Seminars in Oncology Nursing
Frances M Palmieri, Debra L Barton
Clinical Journal of Oncology Nursing
Brett SimchowitzSaul N Weingart
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Debi BhattacharyaSteven Watson
© 2021 Meta ULC. All rights reserved